Disseminated eruptive giant mollusca contagiosa in an adult psoriasis patient during efalizumab therapy.
نویسندگان
چکیده
Molluscum contagiosum is a common viral skin infection in children with atopic diathesis and not rare in HIV patients. We report a 45-year-old psoriasis patient who developed eruptive mollusca contagiosa during an antipsoriatic treatment with efalizumab.
منابع مشابه
Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series
BACKGROUND Newer biological therapies for moderate-to-severe psoriasis are being used more frequently, but unexpected effects may occur. CASE PRESENTATIONS We present a group of 15 patients who developed inflammatory papules while on efalizumab therapy (Raptiva, Genentech Inc, anti-CD11a). Immunohistochemistry showed that there were increased CD11b+, CD11c+ and iNOS+ cells (myeloid leukocytes...
متن کاملCytomegalovirus colitis in a patient treated with efalizumab.
Discussion Efalizumab is a recombinant humanized monoclonal antibody used for chronic plaque psoriasis refractory to other systemic treatments (methotrexate, ciclosporin, PUVA therapy). The most frequent efalizumab side effects are influenza syndrome, infections, pruritus and arthritis [1–4] . Malignancies are not increased in patients treated with efalizumab [5] . A study of the clinical trial...
متن کاملSuccessful treatment of disseminated human papillomavirus infection with pegylated interferon and ribavirin.
We report a case of disseminated human papillomavirus infection that developed in a patient while receiving efalizumab for the treatment of psoriasis. This infection progressed for several months after efalizumab treatment had been stopped. All human papillomavirus lesions completely resolved after 10 weeks of therapy with a combination of pegylated interferon and ribavirin.
متن کاملPsoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series
BACKGROUND Severe psoriasis vulgaris can be extremely difficult to treat in some patients, even with the newer biological therapies available today. CASE PRESENTATIONS We present two patients with severe chronic plaque psoriasis who received numerous systemic anti-psoriatic therapies with varied results. Both responded well to initial treatment with efalizumab (anti-CD11a), but then experienc...
متن کاملEfalizumab for the treatment of psoriatic arthritis.
BACKGROUND Psoriatic arthritis (PsA) is an inflammatory arthritis associated with psoriasis. Efalizumab, a T cell-targeted, recombinant human monoclonal antibody, is approved for the treatment of adult patients with chronic moderate to severe plaque psoriasis. The effect of efalizumab therapy on PsA has not previously been investigated. OBJECTIVE This phase II randomized, double-blind, placeb...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Dermatology
دوره 217 1 شماره
صفحات -
تاریخ انتشار 2008